Secunderabad Chronicle

Microneedle Drug Delivery System Is Poised to Grow at a CAGR of 7% through the Forecast Period : Report Fact.MR

 Breaking News
  • No posts were found

Microneedle Drug Delivery System Is Poised to Grow at a CAGR of 7% through the Forecast Period : Report Fact.MR

August 16
19:41 2021
Microneedle Drug Delivery System Is Poised to Grow at a CAGR of 7% through the Forecast Period : Report Fact.MR
Drug Delivery Systems Market report by “Fact.MR – Market Research And Insights”
Increasing cases of neurological disorders and chronic disease, attributed to the increase in application of oncology and CNS, to spur the sales of drug delivery systems

Fact.MR’s report on global drug delivery systems market projects a strong growth of over 7% CAGR in the forecast period. As per the study, the incorporation of 3-D printing and the nano-technology in drug delivery system is expected to propel the sales in the forecast period. Rising prevalence of chronic diseases such as leukemia, colon cancer are burgeoning the sales of oncology segment. Therefore, bolstering the growth of drug delivery systems.

According to World Health Organization, approximately 5.87 million people in U.S. suffer from neurological disorders and fatal cases. Therefore, such rising cases of neurological disorders is boosting the CNS segment, propelling the sales for drug delivery systems.

Furthermore, according to the Fact.MR study, the ongoing pandemic research activity is set to exhibit a strong growth in the forecast period.

“Key drug delivery systems manufacturers are focusing on adopting nano-technology and technological advancements for the expansion of drug delivery systems,” says the Fact.MR analyst.

Request a report sample to gain comprehensive insights at https://www.factmr.com/connectus/sample?flag=S&rep_id=4768

Key Takeaways

  • Drug delivery systems market to exhibit a growth of nearly 7% CAGR through 2021
  • Targeted drug delivery segment expected to account for almost 50% of market share
  • By application, oncology segment to exhibit the fastest sales through 2021
  • Polymeric drug delivery to register a staggering growth at 7.3% during forecast period
  • Injectable segment to constitute major market share of nearly 44.6% through 2021
  • North America to retain its dominance with over 40% market share
  • Asia Pacific to emerge as lucrative with fastest CAGR of nearly 7.8% through 2021

Prominent Drivers

  • Development of new drugs and biologics to foster the sales
  • Penetration of 3-D printing and electronic drug delivery system to spur drug delivery system sales
  • Application of nanotechnology and prevalence in chronic disease such as leukemia, brain tumor to drive the sales of drug delivery systems

Key Restraints

  • Adverse side effects such as renal impairment, thrombosis to hamper the sales for IVIG application, restraining the growth of drug delivery systems
  • Cytotoxicity of nanoparticles in nano-medicine based drug delivery to restrain the growth of market

Request more information about Report Methodology https://www.factmr.com/connectus/sample?flag=RM&rep_id=4768

global drug delivery systems market 01

Competitive Landscape

Key Drug delivery systems manufacturers profiled by Fact.MR include Novartis AG, Amgen Inc., F.Hoffmann-La Roche Ltd., Pfizer Inc., Johnson & Johnson Services Ltd., Becton, Dickinson and Company, AstraZeneca PLC., Baxter International Inc., Bayer AG and Boston Scientific Corporation among others. According to Fact.MR’s analysis, the drug delivery system market is highly competitive owing to the presence various regional as well as global manufacturers in the market.

In September 2020, FDA accepted supplemental new drug application for Pfizer’s Xalkori (Crizotinib) for the treatment of pediatric alk-positive anaplastic large cell lymphoma. 

More Insights on the Drug delivery systems Market

In its latest report, Fact.MR offers an exhaustive analysis on global drug delivery systems market. In order to understand the global market potential, its growth, and key trends, the market is segmented on the basis of delivery system (intra uterine implants, pro-drug implants, polymeric drug delivery, targeted drug delivery), route of administration (oral, injectable, inhalation, transdermal, ocular, nasal and topical), application (infectious disease, oncology, ophthalmology, urology, diabetes, CNS, and others), and region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa).

Read Fact.MR Exclusive Article on Emerging Frontiers in the Global Dental Industry

https://www.factmr.com/article/110/emerging-frontiers-in-the-global-dental-industry

About Us: 

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner. 
 

Contact:

Neha Bhosle

US Sales Office:

11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: [email protected]
Website: https://www.factmr.com

Media Contact
Company Name: Fact.MR
Contact Person: Neha Bhosle
Email: Send Email
Phone: 6282511583
Address:US Sales Office: 11140 Rockville Pike
City: Rockville
State: Maryland
Country: United States
Website: https://www.factmr.com